In addition to the usual considerations of treating pediatric patients, clinicians should consider how pharmacokinetics may differ for children with obesity, according to a session at the 2021 virtual National Association of Pediatric Nurse Practitioners meeting.
Cardiometabolic health risk factors include metabolic syndrome, a cluster of disorders that include excess fat around the waist, insulin resistance, and high blood pressure.
Being diagnosed with diabetes does not make a person more likely to use effective contraception and may actually lead to a drop in the use of certain types of effective contraception.
Aspects of normal life outside of the pandemic could create difficulties for children with type 1 diabetes, including pressures around food in school.
The study compared an investigational drug called basal insulin Fc (BIF) versus insulin degludec, a commercially available long-lasting daily insulin, in patients with type 2 diabetes.
Women with obesity and polycystic ovarian syndrome (PCOS) have an increased risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
The studies had a minimum follow-up period of 24 weeks and reported at least 1 event of breast cancer or benign breast neoplasm, which included 90,360 participants.
The STEP1 study included 1961 adults with a body mass index (BMI) of 27 or higher with at least 1 weight-related health condition, or a BMI of 30 or higher, without diabetes.
Although ART has helped improve the health of those with HIV, they are at a greater risk of developing complications related to chronic inflammation, such as cardiovascular disease.
New results show that non-Hispanic Black patients with COVID-19 and type 1 diabetes have an additional risk of diabetic ketoacidosis beyond the risk of having diabetes or being of minority status.
Black adults living in rural areas of the United States have experienced higher mortality rates due to diabetes, hypertension, heart disease, and stroke compared to white adults over the past 20 years, according to a research letter published in the Journal of the American College of Cardiology.
Study findings contradict a long-standing hypothesis that held the pancreas increases insulin production because the cells have already become insulin-resistant and blood sugar rises as a result.
Evidence demonstrates that overweight and obesity are risk factors for severe COVID-19.
Sodas have significantly high sugar levels and a lack of nutritional value, which may contribute to conditions that can lead to breast cancer.
Compared to the placebo group, patients with diabetes who received a 54-week course of treatment had higher levels of endogenous insulin secretion with no identified safety concerns.
With schools around the nation reopening, it is time to think about managing diabetes in the classroom.
Insulin plays a key role in regulating female reproductive function, with previous studies showing the effect of insulin deficiency on a woman’s reproductive system.
Both diabetes types lead to severely elevated blood sugar levels that eventually cause a host of possible complications, including loss of limbs and eyesight, kidney damage, diabetic coma, and death.
Investigators have found that the evolutionary sequence of insulin has become stuck at the edge of impaired production, limiting its ability to adapt to obesity and rendering most people vulnerable to type 2 diabetes.
The study found patients who used mHealth applications had better health outcomes and were able to regulate their health behavior more effectively than patients who did not use these apps, in addition to fewer hospital visits and lower medical costs.
Systemic inflammation associated with RA may contribute to the risk of a patient developing type 2 diabetes.
The National DPP is an evidence-based lifestyle change program designed to delay or prevent the onset of type 2 diabetes among adults with prediabetes.
Patients with diabetes have a higher risk of cardiovascular disease and heart failure.
The study measured immune responses from individuals genetically predisposed to developing T1D to naturally occurring insulin and hybrid insulin peptides.
One-third of study participants treated with semaglutide lost at least 20% (46 pounds) of their baseline weight, which is a common reduction for many patients who have had bariatric surgery in the 1 to 3 years following their procedure.
